期刊文献+

大肠息肉及大肠癌TGFβ1、TGFβRⅠ、TGFβRⅡ的表达 被引量:1

The expressions of transforming growth factor β1,TGFβRⅠ and TGFβRⅡ gene in large intestine polyps and cancer
下载PDF
导出
摘要 目的:探讨转化生长因子β1(TGFβ1)、转化生长因子β受体Ⅰ(TGFβRⅠ)、Ⅱ在大肠癌发生中的可能作用。方法:免疫组织化学法检测110例大肠息肉(息肉组,其中高危型大肠腺瘤50例)、各期大肠癌(大肠癌组)40例及正常大肠组织(正常组)20例TGFβ1,TGFβRⅠ、TGFβRⅡ的表达。结果:息肉组、大肠癌组和正常组间TGFβ1、TGFβRⅡ表达差异有统计学意义(P<0.01),而3组间TGFβRⅠ表达差异无统计学意义(P>0.05);高危型大肠腺瘤与Duke's A期大肠癌TGFβ1表达差异有统计学意义(P<0.05),而2组间TGFβRⅠ、TGFβRⅡ表达均无统计学意义(P>0.05)。结论:TGFβ1、TGFβRⅡ在正常组、息肉组、大肠癌组间有不同,提示该指标可能参与大肠癌发生,TGFβ1可能在大肠腺瘤癌变早期起作用。 Objective:To explore the roles of transforming growth factor β1(TGFβ1),TGFβRⅠ and TGFβRⅡ in the development of the large intestine cancer. Methods:The expressions of TGFβ1,TGFβRⅠ and TGFβRⅡ of colorectal adenoma of 50 cases,large intestine cancer of 40 cases and normal tissue of 20 cases were detected through immunohistochemistry. Results:The expressions of TGFβ1 and TGFβRⅡ of the three groups were statistical significant(P〈0.01),but not different for TGFβRⅠ(P〉0.05).The expression of TGFβ1 in colorectal adenoma and large intestine cancer with Duke′s A stage was statistical significant(P〈0.05),but not different for TGFβRⅠ and TGFβRⅡ(P〉0.05). Conclusions:The expressions of TGFβ1 and TGFβRⅡ in normal tissue,colorectal adenoma and large intestine cancer are different,which demonstrate that the expression may participate the forming of large intestine cancer,and TGFβ1 may play some roles in the early stage of colorectal adenoma-carcinoma transition.
出处 《蚌埠医学院学报》 CAS 2012年第9期1045-1048,共4页 Journal of Bengbu Medical College
关键词 大肠肿瘤 转化生长因子Β1 转化生长因子Β受体 tumor of large intestine; transforming growth factor β1; transforming growth factor β receptor
  • 相关文献

参考文献12

  • 1Morson B. The polyp-cancer sequence in the large bowel[ J ]. Proc R Soc Med, 1974,67 (6 Pt 1 ) :451 - 457.
  • 2Winawer S J, Zanber AG, Fletcher RH, et al. Guidelines for colonoscopy surveillance after polypectomy:a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society [ J]. CA Cancer J Clin, 2006,56 ( 3 ) : 143 - 159.
  • 3Huang Y,Waxman S. Enhanced growth inhibition and differentiation of fluorodeoxyuridine-treated human colon carcinoma ceils by phenylbutyrate [ J ]. Clin Cancer Res, 1998,4 ( 10 ) : 2503 - 2509.
  • 4Slattery ML, Herrick JS, Lundgxeen A,et al. Genetic variation in the TGF-13 signaling pathway and colon and rectal cancer risk[ J]. Cancer Epidemiol Biomarkers Prey,2011,20( 1 ) :57 -69.
  • 5Zhang Y, Liu B, J in M, et al. Genetic polymorphisms of transforming growth factor-betal and its receptors and colorectal cancer susceptibility: a population-based case-control study in China[ J]. Cancer Lett,2009,275 ( 1 ) : 102 - 108.
  • 6Cui W, Fowlis DJ, Cousins FM, et al. Concerted action of TGF-β1 and it type II receptor in control of epidermal homeostasis in transgenic mice[ J]. Genes Dev,1995,9(8) :945 -955.
  • 7Are C, Simms N, Rajput A, et al. The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cance [J]. HPB,2010,12(7) :498 -506.
  • 8Markowitz S,Wang J, Myeroff L, et al. Inactivation of the type Ⅱ TGF-beta receptor in colon cancer cells with microsatellite instability [ J]. Science, 1995,268 (5215) : 1336 - 1338.
  • 9Samowitz WS, Slattery ML. Transforming growth factor-beta receptor type 2 mutations and mlcrosatellite instability in sporadic colorectal adenomas and carcinomas [J]. Am J Pathol, 1997,151 (1) :33 -35.
  • 10Yu Y, Kanwar SS, Patel BB, et al. MicroRNA-21 induces sternness by downregulating transforming growth factor beta receptor 2 ( TGFβR2 ) in colon cancer cells [ J ]. Carcinogenesis, 2012,33( 1 ) :68 -76.

同被引文献19

  • 1毛礼蛟,王永征,王晓秋.乳腺肿瘤中CD_(44v6)、TGF-β_1和TGF-βRⅡ的表达与临床和病理特征的关系[J].现代肿瘤医学,2005,13(2):193-196. 被引量:3
  • 2周炎,靳光付,蒋国军,王洪敏,谈永飞,丁伟良,王莉娜,陈文森,柯巧,沈靖,徐耀初,沈洪兵.TGFB1和TGFBR2基因多态与胃癌遗传易感性的关系[J].癌症,2007,26(6):581-585. 被引量:5
  • 3郑伟,王家富,张宾,黄庆玉,景斐.TGF-β_1、TβRII在子宫内膜样腺癌中的表达及其意义[J].泰山医学院学报,2007,28(8):579-582. 被引量:1
  • 4Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CACancer J Clin,2013,63(1): 11 -30.
  • 5Tian M, Neil J R, Schiemann W P. Transforming growth factor- pand the hallmarks of cancer[J].Cell Signal,2011,23(6):951 -962.
  • 6Levy L, Hill C S. Alterations in components of the TGF-betasuperfamily signaling pathways in human cancer [J]. CytokineGrowth Factor Rev,2006,17(1 ):41 -58.
  • 7Bierie Z,Stover D G.Abel T W, et al.Transforming growth factor- pregulates mammary carcinoma cell survival and interaction withthe adjacent microenvironment[J]. Cancer Res, 2008, 68(6):1809-1819.
  • 8Ma X, Beeghly-Fadiel A, Lu W, et al. Pathway analyses identifyTGFBR2 as potential breast cancer susceptibility gene: resultsfrom a consortium study among Asians [J]. Cancer EpidemiolBiomarkers Prev, 2012, 21(7):1176-1184.
  • 9Feng X H, Derynck R. Specificity and versatility in tgf-beta signal-ing through Smads[J].Annu Rev Cell Dev Biol,2005,21(1):659-693.
  • 10Zhang M,Guo L L,Cheng Z,et al. A functional polymorphism ofTGFBR2 is associated with risk of breast cancer with ER (+), PR(+), ER(+)PR(+) and HER2(-) expression in women [J]. OncolLett, 2011,2(4):653-658.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部